Page last updated: 2024-11-06

mycobacidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Mycobacidin is a potent and selective inhibitor of the bacterial enzyme mycothiol S-conjugate amidase (Mca). This enzyme is essential for the detoxification of electrophilic compounds in mycobacteria, including Mycobacterium tuberculosis, the causative agent of tuberculosis. Mycobacidin acts by binding to the active site of Mca and preventing its catalytic activity. The compound has been shown to be effective against both drug-susceptible and drug-resistant strains of M. tuberculosis in vitro and in vivo. Mycobacidin is a promising lead compound for the development of new antituberculosis drugs. Research on mycobacidin is important because it is a potential new therapeutic agent for the treatment of tuberculosis, a disease that still affects millions of people worldwide.'

mycobacidin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID94170
CHEMBL ID4862934
SCHEMBL ID1021205
MeSH IDM0055613

Synonyms (23)

Synonym
nsc-28674
nsc28674
acidomycin
mycobacidin
actithiazic acid
cinnamonin
4-oxo-2-thiazolidinehexanoic acid
2-thiazolidinehexanoic acid, 4-oxo-
FT-0659477
539-35-5
6-(4-oxo-1,3-thiazolidin-2-yl)hexanoic acid
unii-ux05p33k8j
ux05p33k8j ,
28223-69-0
SCHEMBL1021205
mycobacidin dl-form [mi]
mycobacidin [mi]
DTXSID10275924
6-(4-oxothiazolidin-2-yl)hexanoic acid
Q27291311
STARBLD0000876
DTXSID80871750
CHEMBL4862934
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1756875Antimycobacterial activity against Mycobacterium tuberculosis HN878 measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756876Antimycobacterial activity against Mycobacterium tuberculosis Erdman measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756877Antimycobacterial activity against multidrug resistant Mycobacterium tuberculosis measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756873Antimycobacterial activity against Mycobacterium tuberculosis H37Rv measured after 11 to 12 days2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756881Antimycobacterial activity Mycobacterium bovis BCG measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756874Antimycobacterial activity against Mycobacterium tuberculosis measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756878Antimycobacterial activity against ethambutol/pyrazinamide/kanamycin/streptomycin/ofloxacin/moxifloxacin/levofloxacin resistant Mycobacterium tuberculosis measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756879Antimycobacterial activity against extensively drug resistant Mycobacterium tuberculosis measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
AID1756880Antimycobacterial activity against Mycobacterium africanum measured up to 2 weeks2021European journal of medicinal chemistry, Apr-05, Volume: 215Antitubercular properties of thiazolidin-4-ones - A review.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-199011 (73.33)18.7374
1990's2 (13.33)18.2507
2000's0 (0.00)29.6817
2010's1 (6.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.71 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.25%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (93.75%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]